Yellow Fever Vaccine
Overview
A freeze-dried preparation of the strains of yellow fever virus grown in fertilized hen eggs. It is used for active immunization against yellow fever. Immunity is usually established within about 10 days of administration. It is recommended for laboratory workers handling infected material or persons travelling through, or living in areas of infection.
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Yellow Fever Vaccine's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| No data regarding the Adult dosage details of Yellow Fever Vaccine is available. |
Paedriatic Dosage (20kg)
|
| 0.5 ml | 0.5 (0.5) | As recommended. | SC | Infants under 4 months of age should not be vaccinated. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Yellow Fever Vaccine is available. |
High Risk Groups
Drug should not be given to Pregnant Mothers, and Neonates.
If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Yellow Fever Vaccine
Back to top
Manufacturers of
Yellow Fever Vaccine
in Pakistan
Back to top
Previous Drug Generic - Next Drug Generic